World news and discussion on TalkFuse.
Chinese genetic firm Novogene sues US over military designation
Chinese genetic sequencing firm Novogene is suing the US Pentagon over its designation as a company allegedly aiding China’s military. It says the listing is unlawful and has caused serious economic and reputational harm; the case adds to a series of challenges by Chinese firms to the US blacklist.
The Pentagon added Novogene to the list in June alongside Alibaba, Baidu, BYD and NIO. The designation bars direct Pentagon contracts and, from 2027, is set to restrict purchases through third parties, though it is not a formal sanction. Novogene says its US unit employs about 180 people in Sacramento and operates sequencing centres in California and Oregon, and that it does not make products for military use.
In short
- Novogene is challenging its US military-company designation in court.
- It says the listing has caused economic and reputational harm.
- Restrictions on Pentagon purchases through third parties begin in 2027.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
The US can argue that identifying companies suspected of supporting a foreign military is a proportionate way to protect national security and limit the Pentagon’s exposure to potential military-linked suppliers. The designation is not a formal sanction, and the government may consider that acting before a risk is conclusively demonstrated is prudent given the sensitivity of genetic sequencing technology.
The case against
Novogene can argue that a serious government designation should rest on reliable evidence and a fair process, particularly when it restricts future business and can damage a company’s reputation. It says it does not make products for military use, and points to its US workforce and facilities as evidence that the listing also harms legitimate local operations; a court challenge can test whether the government acted lawfully.
Explained simply
Novogene is a Chinese company that reads and analyses DNA, a process used in areas such as medical research and biotechnology. It also operates in the United States, where the company says its local unit employs about 180 people and runs sequencing centres in California and Oregon.
The Pentagon is the US defence department. Its list identifies companies it says support China’s military; inclusion can affect access to defence-related business, including contracts made through other companies. The list also includes major Chinese firms such as Alibaba, Baidu, BYD and NIO.
The dispute matters because the designation can affect a company’s business and reputation even though it is not a formal sanction. Novogene says its work is not for military use, while the US listing reflects the Pentagon’s assessment of the company.